Literature DB >> 23857680

Impact of pulmonary rehabilitation on quality of life and functional capacity in patients on waiting lists for lung transplantation.

Juliessa Florian1, Adalberto Rubin, Rita Mattiello, Fabrício Farias da Fontoura, José de Jesus Peixoto Camargo, Paulo Jose Zimermann Teixeira.   

Abstract

OBJECTIVE: To investigate the impact of a pulmonary rehabilitation program on the functional capacity and on the quality of life of patients on waiting lists for lung transplantation.
METHODS: Patients on lung transplant waiting lists were referred to a pulmonary rehabilitation program consisting of 36 sessions. Before and after the program, participating patients were evaluated with the six-minute walk test and the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36). The pulmonary rehabilitation program involved muscle strengthening exercises, aerobic training, clinical evaluation, psychiatric evaluation, nutritional counseling, social assistance, and educational lectures.
RESULTS: Of the 112 patients initially referred to the program, 58 completed it. The mean age of the participants was 46 ± 14 years, and females accounted for 52%. Of those 58 patients, 37 (47%) had pulmonary fibrosis, 13 (22%) had pulmonary emphysema, and 18 (31%) had other types of advanced lung disease. The six-minute walk distance was significantly greater after the program than before (439 ± 114 m vs. 367 ± 136 m, p = 0.001), the mean increase being 72 m. There were significant point increases in the scores on the following SF-36 domains: physical functioning, up 22 (p = 0.001), role-physical, up 10 (p = 0.045); vitality, up 10 (p < 0.001); social functioning, up 15 (p = 0.001); and mental health, up 8 (p = 0.001).
CONCLUSIONS: Pulmonary rehabilitation had a positive impact on exercise capacity and quality of life in patients on lung transplant waiting lists.

Entities:  

Mesh:

Year:  2013        PMID: 23857680      PMCID: PMC4075851          DOI: 10.1590/S1806-37132013000300012

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


Introduction

Patients with advanced lung disease experience a dyspnea- and fatigue-related reduction in exercise tolerance. In recent decades, numerous strategies associated with pharmacological treatment have been studied to reduce symptoms and improve quality of life in these patients.( ) Pulmonary rehabilitation, which is considered a non-pharmacological intervention with a high level of evidence (grade of recommendation A) in the treatment of COPD, improves exercise tolerance and is fundamentally based on physical training, which, together with the other strategies, aims to relieve and control symptoms, minimize the complications of the disease, and help patients live an active life with few restrictions.( - ) Some studies have suggested that the benefits of a rehabilitation program are not associated with the stage of disease severity, and that rehabilitation should be recommended at any stage.( - ) For patients with advanced lung disease, lung transplantation is a treatment option that has contributed to improving quality of life and increasing survival.( - ) Recent studies have demonstrated the benefits that pulmonary rehabilitation can bring to patients after lung transplantation.( , , ) The benefits of rehabilitation in patients on lung transplant waiting lists are not yet conclusive, because previous studies have involved a small number of patients, heterogeneous samples, and different intervention protocols. Jastrzebski et al.( ) used the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) to assess quality of life in 16 waiting list patients with idiopathic pulmonary fibrosis and 14 waiting list patients with COPD at two time points: at the time of referral for lung transplantation and one year later. Those authors found that there was worsening in the role-physical domain, and that the patients with COPD had worse scores than did those with pulmonary fibrosis. Therefore, pre-transplant pulmonary rehabilitation is essential to minimize loss of functional performance while patients are awaiting transplantation.( ) The hypothesis of the present study was that patients on lung transplant waiting lists who participate in an individualized, multidisciplinary pulmonary rehabilitation program would experience benefits in terms of both exercise tolerance and health-related quality of life. The objective of the present study was to analyze the impact of a pulmonary rehabilitation program on the functional capacity and quality of life of patients on lung transplant waiting lists.

Methods

This was a prospective study conducted in the Department of Pulmonary Rehabilitation of the Pereira Filho Ward, Department of Lung Diseases of the Santa Casa Hospital Complex in Porto Alegre, Porto Alegre, Brazil. The research project was approved by the Research Ethics Committee of the Santa Casa Hospital Complex in Porto Alegre. All patients gave written informed consent, agreeing to participate in the study. Between June of 2007 and November of 2010, the study included patients with advanced lung disease who were undergoing optimized drug therapy and were placed on lung transplant waiting lists in accordance with the criteria established in the international guidelines for the selection of lung transplant candidates. ( ) Considering the broad base of evidence supporting the recommendation of pulmonary rehabilitation for patients with advanced lung disease, participation in rehabilitation is one of the criteria for remaining on waiting lists and is recommended by the lung transplant team of the Santa Casa Hospital Complex in Porto Alegre. The clinical information about the diagnosis was collected from the medical charts of the patients. The pulmonary function tests were performed in accordance with the technical procedures and the acceptability and reproducibility criteria of the American Thoracic Society/European Respiratory Society and the Brazilian Thoracic Association (BTA). ( - ) The tests were performed in the pulmonary function laboratory of our institution, which is a laboratory certified by the BTA. The pulmonary rehabilitation program involved the following steps: medical appointments with the transplant team every two months; psychiatric evaluations, nutritional counseling, social assistance, and monthly educational lectures. The physical training was administered by two physical therapists. The sessions, each lasting 90 minutes, took place three times a week, totaling 36 meetings. The following activities were performed: warming-up, which consisted of breathing exercises (respiratory cycle) associated with arm raising; and muscle strengthening, which was based on arm and leg exercises with an initial load of 30% of one repetition maximum testing and with one set of 10 repetitions per exercise.( ) The load was increased by 0.5 kg every 7 sessions according to the patient tolerance. Aerobic exercises were performed on a treadmill (Inbrasport, Porto Alegre, Brazil), beginning at 60% of the speed of the patient on the six-minute walk test (6MWT), with a progressive protocol every 6 minutes for the variable time until reaching 30 minutes. The speed was increased by 0.3 km/h every 7 sessions. The completion of all exercises was limited when the patient reported dyspnea or leg fatigue, indicated by a modified Borg scale score greater than 4, and when the SpO2 reached 92%. At the end of each session, stretching was performed for the major muscle groups involved. During the rehabilitation program, all patients received continuous oxygen therapy in accordance with the medical prescription and were constantly monitored by pulse oximetry. An oxygen flow required to maintain an SpO2 ≥ 92% was used. Before and after the 36 sessions, the patients were evaluated by the same physical therapists with the 6MWT, in accordance with the American Thoracic Society recommendations, and the SF-36.( , ) The modified Borg scale was used for measuring dyspnea and leg discomfort.( ) Data analysis was performed with the Statistical Package for the Social Sciences, version 14.0 (SPSS Inc, Chicago, IL, USA). Distribution of symmetrical variables was assessed by the Kolmogorov-Smirnov test. Continuous variables are expressed as mean and standard deviation or as median and interquartile range, whereas categorical variables are expressed as absolute and relative frequency. The study outcomes before and after the rehabilitation sessions were compared with the Student's t-test for paired samples. The chi-square test was used for continuous variables, and the Mann-Whitney U test was used for categorical variables. The level of significance was set at 5%.

Results

During the study period, 112 patients were placed on lung transplant waiting lists and referred for pulmonary rehabilitation. Of those, 54 did not complete the 36 sessions of the program and were excluded from the study. The reasons for not completing the rehabilitation program were as follows: having undergone lung transplantation before the end of the program, 43 patients; having died, 8 patients; having given up transplantation, 2 patients; and having been hospitalized for a long time, 1 patient (Figure 1). Table 1 shows the comparison of demographic and functional characteristics between the 58 patients (53.7%) who completed the program and the 54 (47.3%) who were excluded. The only variable for which there was a significant difference between the groups was age. The patients who underwent the entire program were, on average, 5 years younger than were those who were excluded.
Figure 1

Flowchart of patient inclusion in the study.

Table 1

Baseline characteristics of the sample of lung transplant candidates who were prescribed the pulmonary rehabilitation program.

VariableParticipantsNon-participantsp
(n = 58)(n = 54)
Demography
Male gender, n (%)28 (48)27 (63)0.163
Age, years 46 ± 1451 ± 11< 0.001
Anthropometry
BMI, kg/m2 23 ± 424 ± 30.162
Diagnosis, n (%)
Idiopathic pulmonary fibrosis27(47)22(51)0.199
Pulmonary emphysema13 (22)14 (32)
Others b 18 (31)7 (16)
Pulmonary function c
FVC, L 1.12 ± 0.60.95 ± 0.40.172
FVC, % of predicted44.9 ± 16.541.1 ± 11.30.194
FEV1, L0.43 ± 0.620.39 ± 0.490.853
FEV1, % of predicted32.9 ± 15.931.6 ± 16.80.695
FEV1/FVC0.44 ± 0.490.34 ± 0.440.316
6MWT
6MWD, m367 ± 136330 ± 1350.992
6MWD, % of predicted56.6 ± 22.648.7 ± 24.80.082
PASP, mmHg44.8 ± 17.342.9 ± 17.10.580

: body mass index

: six-minute walk test

: six-minute walk distance

: pulmonary artery systolic pressure

Values expressed as mean ± SD, except where otherwise indicated

Lymphangioleiomyomatosis, bronchiolitis obliterans, and pneumoconiosis.

Post-bronchodilator pulmonary function tests

: body mass index : six-minute walk test : six-minute walk distance : pulmonary artery systolic pressure Values expressed as mean ± SD, except where otherwise indicated Lymphangioleiomyomatosis, bronchiolitis obliterans, and pneumoconiosis. Post-bronchodilator pulmonary function tests The results obtained before and after the rehabilitation program for the 6MWT variables are shown in Table 2. After completion of the program, there was a mean increase of 72 m in the six-minute walk distance (6MWD), and there was a significant decrease in perceived dyspnea. Resting and post-exercise SpO2 remained similar after the program, there being no statistically significant difference. The patients walked a greater distance and did not have greater desaturation because of the increased effort, reporting a lesser degree of dyspnea after the rehabilitation program. There was no difference in perceived leg fatigue at rest before and after the sessions; however, after completion of the program, the patients reported less discomfort, this difference being statistically significant.
Table 2

Comparison of the six-minute walk test variables before and after the pulmonary rehabilitation program (n = 58).

VariablePulmonary rehabilitation programp
BeforeAfter b
6MWD, m367 ± 136439 ± 11472 (50-95)0.001
6MWD, % of predicted56,6 ± 22,675,5 ±16,619 (58-92)0.001
Resting SpO2 , %95 ± 294 ± 32 (1-2)0.001
Post-exercise SpO2 , %80 ± 980 ± 90 (−2 to 2)0.940
Modified Borg scale
Resting dyspnea0 (0−2) c 0 (0−0) c −1 (−1 to 0)0.001
Post-exercise dyspnea5 (3−7) c 4 (3−5) c −1 (−2 to 0)0.001
Leg fatigue at rest0 (0−0) c 0 (0−0) c 0 (0−0)0.129
Leg fatigue after exercise3 (0−5) c 2 (0−3) c −1 (−2 to 0)0.011

: variation (measurement after the rehabilitation program - measurement before the rehabilitation program)

: six-minute walk distance

Values expressed as mean ± SD, except where otherwise indicated

Values expressed as mean (95% CI).

Values expressed as median (interquartile range)

: variation (measurement after the rehabilitation program - measurement before the rehabilitation program) : six-minute walk distance Values expressed as mean ± SD, except where otherwise indicated Values expressed as mean (95% CI). Values expressed as median (interquartile range) There were significant point increases in the scores on the following SF-36 domains: physical functioning, up 22 (p = 0.001), role-physical, up 10 (p = 0.045); vitality, up 10 (p < 0.001); social functioning, up 15 (p = 0.001); and mental health, up 8 (p = 0.001). No statistically significant differences were found for the other domains (Table 3).
Table 3

Comparison of the domains of the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) before and after the pulmonary rehabilitation program (n = 58).

VariablePulmonary rehabilitation programp
BeforeAfter b
Physical functioning20 (10-35)45 (30-55)22 (17-26)< 0.001
Role-physical0 (0-25)06 (0-50)10 (1-19)0.045
Bodily pain62 (41-90)74 (51-9)6 (−1 to 14)0.055
General health30 (20-52)36 (22-52)4 (−2 to 9)0.151
Vitality57 (38-75)65 (53-81)10 (5-14)< 0.001
Social functioning50 (25-75)64 (50-87)15 (8-21)< 0.001
Role-emotional33 (0-100)66 (0-100)12 (−1 to 25)0.087
Mental health82 (64-88)84 (79-92)8 (4-13)0.001

variation (measurement after the rehabilitation program - measurement before the rehabilitation program).

Values expressed as median (interquartile range), except where otherwise indicated

Values expressed as mean (95% CI)

variation (measurement after the rehabilitation program - measurement before the rehabilitation program). Values expressed as median (interquartile range), except where otherwise indicated Values expressed as mean (95% CI)

Discussion

In the present study, lung transplant candidates who participated in an individualized, multidisciplinary pulmonary rehabilitation program showed significant clinical improvement in the 6MWT and in quality of life. The mean increase of 72 m in the 6MWD and the increase in the SF-36 physical functioning, role-physical, vitality, social functioning, and mental health domain scores, both of which observed after 36 sessions of aerobic exercise training and muscle strengthening, emphasize that pulmonary rehabilitation provides overall benefits to the health of this population. The benefits of pulmonary rehabilitation in patients with COPD and pulmonary fibrosis have been well documented.( , , ) In patients with COPD, rehabilitation has proven to improve exercise tolerance, to reduce dyspnea, to improve quality of life, and to reduce the use of health resources. As adjuvant treatment to surgical programs, such as lung volume reduction surgery, rehabilitation plays an important role in the preparation of these patients for the procedure, facilitating postoperative recovery.( , ) In the present study, most patients had pulmonary fibrosis and emphysema. In a study in which 30 patients with idiopathic pulmonary fibrosis were compared with 15 control group patients who did not undergo rehabilitation, those who underwent pulmonary rehabilitation obtained an increase of 46.3 m (95% CI: 8.3-84.4; p < 0.05) in the 6MWD.( ) A study involving 13 patients with idiopathic pulmonary fibrosis showed that, after a pulmonary rehabilitation program, there was a reduction in perceived dyspnea, as measured by the Borg scale, from 3.0 ± 1.4 to 2.5 ± 1.4 (p < 0.01).( ) Although, in the present study, we did not analyze the underlying diseases separately, we found a significant improvement in the functional capacity and quality of life of the patients who completed the rehabilitation program. In a prospective cohort study involving 376 patients on lung transplant waiting lists, the baseline 6MWD was analyzed as a predictor of survival in that population. Those authors found that post-transplant survival increased significantly as the 6MWD values increased in comparison with baseline values. In addition, they found that this relationship is similar in all types of lung disease; this reveals the possibility that rehabilitation programs in the pre-transplant phase can provide a favorable impact during hospitalization. The patients in the present study had a higher mean 6MWD after the rehabilitation program, which allows us to infer a higher probability of post-transplant survival.( , ) All of our patients underwent continuous training on a treadmill, i.e., a conventional program. A randomized clinical trial investigated different modes of exercise (interval vs. continuous) in lung transplant candidates and found that there was an increase in the 6MWD in the two groups studied, with a greater reduction in dyspnea occurring in the group receiving interval training.( ) In another study, a different mode of training, i.e., Nordic walking with ski poles, was used for twelve weeks in a pulmonary rehabilitation program in lung transplant candidates. Those authors observed a significant increase in mean 6MWD (310.2 m vs. 372.1 m; p < 0.05) and improvement in the SF-36 social functioning domain (p < 0.05), demonstrating that the type of training was safe and feasible.( ) Most of the current pulmonary rehabilitation programs, designed for lung transplant candidates, comply with the general recommendations for pulmonary rehabilitation, with a weekly frequency of two to three sessions per week, over a period of six to eight weeks. These programs include aerobic training, arm and leg muscle strengthening, and also an educational component, which, in addition to the aspects of the disease that are commonly addressed, needs to include issues relevant to the procedure itself, educating patients regarding immunosuppressive drugs, rejection, infections, and complications so that they can adopt a new lifestyle.( , , , ) Considering that, of the 112 patients referred to our program, most completed it, it should be emphasized that many of the excluded patients from the analysis were excluded because they underwent transplantation. The excellent adherence to the program in our study population can be explained by the fact that pulmonary rehabilitation is included in the preoperative treatment plan for this group of patients who are highly motivated for surgery. Patients who are preparing for lung transplantation represent a selected group of individuals with advanced chronic respiratory disease and often remain on waiting lists for long periods of time. Since maintaining health status, exercise capacity, and quality of life are key factors for a highly complex surgical procedure, ongoing maintenance of these patients in a rehabilitation program would be a desirable strategy.( , , ) In this context, a determining factor in the success of rehabilitation programs would be patient adherence to scheduled sessions.( ) A study involving 711 patients referred for pulmonary rehabilitation demonstrated that 31.8% of those patients did not attend the programs and that, of those who did, 29.1% were non-adherent. Using a logistic regression model, those researchers observed that use of long-term oxygen therapy and living alone were independent factors for non-attendance. In addition, being a current smoker, performing poorly on the shuttle test, and hospitalizations were independent predictors of poor adherence.( ) Since this group of patients is only one of the several groups that use pulmonary rehabilitation, we have established a rotation strategy for those remaining on waiting lists for long periods of time. This strategy, which provides access to rehabilitation opportunities for all, was based on a study in which the authors concluded that the benefits of a rehabilitation program on the indices of anxiety, depression, quality of life, and exercise capacity persisted over 24 months in patients with COPD.( ) Among the limitations of our study is the lack of a control group, the use of which was considered by us, in the preparation of the protocol, to be an unethical strategy, given that various studies have emphasized the importance of rehabilitation in advanced lung disease. The fact that cardiopulmonary exercise testing was not used might have underestimated the training strategy of these patients, preventing them from further improving their exercise capacity. Another factor that can be considered a limitation is the lack of an analysis of the emotional aspects of these patients, who view transplantation as their last chance of improving their disease outcome. The findings of the present study allow us to conclude that the individualized, multidisciplinary pulmonary rehabilitation program was beneficial for patients on lung transplant waiting lists. The patients who participated in the program showed significant clinical improvement after 36 physical training sessions, as well as showing improvement in the 6MWD and in quality of life, which underscores the need for rehabilitation programs at facilities performing complex surgical procedures, such as lung transplantation.
  29 in total

Review 1.  [Inhaled therapies for cystic fibrosis].

Authors:  Samir Lahzami; Laurent P Nicod
Journal:  Rev Med Suisse       Date:  2011-11-23

Review 2.  New tools in pulmonary rehabilitation.

Authors:  P J Wijkstra; J B Wempe
Journal:  Eur Respir J       Date:  2011-08-04       Impact factor: 16.671

3.  Effect of inpatient rehabilitation on quality of life and exercise capacity in long-term lung transplant survivors: a prospective, randomized study.

Authors:  Franziska Ihle; Claus Neurohr; Patrick Huppmann; Gregor Zimmermann; Hanno Leuchte; Rainer Baumgartner; Klaus Kenn; Bernd Sczepanski; Rudolf Hatz; Stephan Czerner; Lorenz Frey; Peter Ueberfuhr; Iris Bittmann; Jürgen Behr
Journal:  J Heart Lung Transplant       Date:  2011-04-13       Impact factor: 10.247

4.  Predictors of benefit following pulmonary rehabilitation for interstitial lung disease.

Authors:  Anne E Holland; Catherine J Hill; Ian Glaspole; Nicole Goh; Christine F McDonald
Journal:  Respir Med       Date:  2011-12-17       Impact factor: 3.415

5.  Pulmonary rehabilitation in patients referred for lung transplantation.

Authors:  D Jastrzebski; M Ochman; D Ziora; L Labus; K Kowalski; J Wyrwol; W Lutogniewska; M Maksymiak; B Ksiazek; A Magner; A Bartoszewicz; P Kubicki; G Hydzik; A Zebrowska; J Kozielski
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 6.  Determinants of success.

Authors:  R Garrod; M Malerba; E Crisafulli
Journal:  Eur Respir J       Date:  2011-06-30       Impact factor: 16.671

7.  Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade.

Authors:  R A Evans; S J Singh; R Collier; J E Williams; M D L Morgan
Journal:  Respir Med       Date:  2009-02-13       Impact factor: 3.415

8.  Interval versus continuous training in lung transplant candidates: a randomized trial.

Authors:  Rainer Gloeckl; Martin Halle; Klaus Kenn
Journal:  J Heart Lung Transplant       Date:  2012-09       Impact factor: 10.247

9.  Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence.

Authors:  Conal Hayton; Allan Clark; Sandra Olive; Paula Browne; Penny Galey; Emma Knights; Lindi Staunton; Andrew Jones; Emma Coombes; Andrew M Wilson
Journal:  Respir Med       Date:  2012-12-19       Impact factor: 3.415

10.  Making decisions about service delivery in early childhood programs.

Authors:  Jane Case-Smith; Terri Holland
Journal:  Lang Speech Hear Serv Sch       Date:  2009-10       Impact factor: 2.983

View more
  14 in total

Review 1.  Lung transplantation: a treatment option in end-stage lung disease.

Authors:  Marc Hartert; Omer Senbaklavacin; Bernhard Gohrbandt; Berthold M Fischer; Roland Buhl; Christian-Friedrich Vahld
Journal:  Dtsch Arztebl Int       Date:  2014-02-14       Impact factor: 5.594

Review 2.  Preoperative physiotherapy in subjects with idiopathic pulmonary fibrosis qualified for lung transplantation: implications on hospital length of stay and clinical outcomes.

Authors:  Massimiliano Polastri; Andrea Dell'Amore; Giulia Zagnoni; Stefano Nava
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

3.  Effect of 8-week Pulmonary Rehabilitation Program on Dyspnea and Functional Capacity of Patients on Waiting List for Lung Transplantation.

Authors:  Lütfiye Kılıç; Esra Pehlivan; Arif Balcı; Nur Dilek Bakan
Journal:  Turk Thorac J       Date:  2020-03-01

4.  A 1-Month Physical Therapy-Based Outpatient Program for Adults Awaiting Lung Transplantation: A Retrospective Analysis of Exercise Capacity, Symptoms, and Quality of Life.

Authors:  Rebecca Byrd; Patrick Smith; Omar Mohamedaly; Laurie D Snyder; Amy M Pastva
Journal:  Cardiopulm Phys Ther J       Date:  2019-04

5.  Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China.

Authors:  Luca Richeldi; Adalberto Sperb Rubin; Sergey Avdeev; Zarir F Udwadia; Zuo Jun Xu
Journal:  BMC Med       Date:  2015-09-24       Impact factor: 8.775

Review 6.  Effects of pulmonary rehabilitation in lung transplant candidates: a systematic review.

Authors:  Mariana Hoffman; Gabriela Chaves; Giane Amorim Ribeiro-Samora; Raquel Rodrigues Britto; Verônica Franco Parreira
Journal:  BMJ Open       Date:  2017-02-03       Impact factor: 2.692

Review 7.  A global perspective of lung transplantation: Part 1 - Recipient selection and choice of procedure.

Authors:  Reda E Girgis; Asghar Khaghani
Journal:  Glob Cardiol Sci Pract       Date:  2016-03-31

8.  Exercise Training in Patients With Non-Small Cell Lung Cancer During In-Hospital Chemotherapy Treatment: A RANDOMIZED CONTROLLED TRIAL.

Authors:  Anna Rutkowska; Dariusz Jastrzebski; Sebastian Rutkowski; Aleksandra Żebrowska; Arkadiusz Stanula; Jan Szczegielniak; Dariusz Ziora; Richard Casaburi
Journal:  J Cardiopulm Rehabil Prev       Date:  2019-03       Impact factor: 2.081

9.  Pulmonary rehabilitation improves survival in patients with idiopathic pulmonary fibrosis undergoing lung transplantation.

Authors:  Juliessa Florian; Guilherme Watte; Paulo José Zimermann Teixeira; Stephan Altmayer; Sadi Marcelo Schio; Letícia Beatriz Sanchez; Douglas Zaione Nascimento; Spencer Marcantonio Camargo; Fabiola Adélia Perin; José de Jesus Camargo; José Carlos Felicetti; José da Silva Moreira
Journal:  Sci Rep       Date:  2019-06-27       Impact factor: 4.379

Review 10.  Physical rehabilitation for lung transplant candidates and recipients: An evidence-informed clinical approach.

Authors:  Lisa Wickerson; Dmitry Rozenberg; Tania Janaudis-Ferreira; Robin Deliva; Vincent Lo; Gary Beauchamp; Denise Helm; Chaya Gottesman; Polyana Mendes; Luciana Vieira; Margaret Herridge; Lianne G Singer; Sunita Mathur
Journal:  World J Transplant       Date:  2016-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.